文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Targeting Shank3 deficiency and paresthesia in autism spectrum disorder: A brief review.

作者信息

Huang Min, Qi Qi, Xu Tao

机构信息

Department of Anesthesiology, Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Anesthesiology, Suzhou Hospital of Anhui Medical University, Suzhou, China.

出版信息

Front Mol Neurosci. 2023 Feb 9;16:1128974. doi: 10.3389/fnmol.2023.1128974. eCollection 2023.


DOI:10.3389/fnmol.2023.1128974
PMID:36846568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9948097/
Abstract

Autism spectrum disorder (ASD) includes a group of multifactorial neurodevelopmental disorders characterized by impaired social communication, social interaction, and repetitive behaviors. Several studies have shown an association between cases of ASD and mutations in the genes of SH3 and multiple ankyrin repeat domain protein 3 (SHANK3). These genes encode many cell adhesion molecules, scaffold proteins, and proteins involved in synaptic transcription, protein synthesis, and degradation. They have a profound impact on all aspects of synaptic transmission and plasticity, including synapse formation and degeneration, suggesting that the pathogenesis of ASD may be partially attributable to synaptic dysfunction. In this review, we summarize the mechanism of synapses related to Shank3 in ASD. We also discuss the molecular, cellular, and functional studies of experimental models of ASD and current autism treatment methods targeting related proteins.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf0/9948097/e2fa11d5d044/fnmol-16-1128974-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf0/9948097/e2fa11d5d044/fnmol-16-1128974-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf0/9948097/e2fa11d5d044/fnmol-16-1128974-g001.jpg

相似文献

[1]
Targeting Shank3 deficiency and paresthesia in autism spectrum disorder: A brief review.

Front Mol Neurosci. 2023-2-9

[2]
Synaptopathology Involved in Autism Spectrum Disorder.

Front Cell Neurosci. 2018-12-21

[3]
Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications.

J Neurodev Disord. 2021-11-16

[4]
Targeting of δ-catenin to postsynaptic sites through interaction with the Shank3 N-terminus.

Mol Autism. 2020-10-28

[5]
Dietary Zinc Supplementation Prevents Autism Related Behaviors and Striatal Synaptic Dysfunction in Exon 13-16 Mutant Mice.

Front Cell Neurosci. 2018-10-22

[6]
Influence of maternal zinc supplementation on the development of autism-associated behavioural and synaptic deficits in offspring Shank3-knockout mice.

Mol Brain. 2020-8-5

[7]
The association of SHANK3 gene polymorphism and autism.

Minerva Pediatr (Torino). 2021-6

[8]
Autism-associated Shank3 mutations alter mGluR expression and mGluR-dependent but not NMDA receptor-dependent long-term depression.

Synapse. 2019-3-23

[9]
Association between SHANK3 polymorphisms and susceptibility to autism spectrum disorder.

Gene. 2018-4-20

[10]
Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication.

Mol Autism. 2010-12-17

引用本文的文献

[1]
Progress toward a comprehensive brain protein interactome.

Biochem Soc Trans. 2025-2-12

[2]
Talin, a Rap1 effector for integrin activation at the plasma membrane, also promotes Rap1 activity by disrupting sequestration of Rap1 by SHANK3.

J Cell Sci. 2025-2-15

[3]
Research progress on melatonin, 5-HT, and orexin in sleep disorders of children with autism spectrum disorder.

Biomol Biomed. 2025-1-30

[4]
Decoding the genetic landscape of autism: A comprehensive review.

World J Clin Pediatr. 2024-9-9

[5]
A bibliometric analysis of autism spectrum disorder signaling pathways research in the past decade.

Front Psychiatry. 2024-2-12

本文引用的文献

[1]
A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder.

Exp Brain Res. 2022-10

[2]
A recurrent SHANK1 mutation implicated in autism spectrum disorder causes autistic-like core behaviors in mice via downregulation of mGluR1-IP3R1-calcium signaling.

Mol Psychiatry. 2022-7

[3]
Absence of familiarity triggers hallmarks of autism in mouse model through aberrant tail-of-striatum and prelimbic cortex signaling.

Neuron. 2022-5-4

[4]
Shankopathies in the Developing Brain in Autism Spectrum Disorders.

Front Neurosci. 2021-12-22

[5]
New Candidates for Autism/Intellectual Disability Identified by Whole-Exome Sequencing.

Int J Mol Sci. 2021-12-14

[6]
Decrease of morphine-CPP by sinomenine via mediation of tyrosine hydroxylase, NMDA receptor subunit 2B and opioid receptor in the zebrafish brain.

Pak J Pharm Sci. 2021-9

[7]
Homer1a regulates Shank3 expression and underlies behavioral vulnerability to stress in a model of Phelan-McDermid syndrome.

Cell Rep. 2021-11-16

[8]
Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications.

J Neurodev Disord. 2021-11-16

[9]
Auditory hypersensitivity and processing deficits in a rat model of fragile X syndrome.

Neurobiol Dis. 2021-12

[10]
Parent-reported measure of repetitive behavior in Phelan-McDermid syndrome.

J Neurodev Disord. 2021-11-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索